Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS)



Similar documents
Teriflunomide (Aubagio) 14mg once daily tablet

Gilenya. Exceptional healthcare, personally delivered

Intravenous Methyl Prednisolone in Multiple Sclerosis

Albumin. Prothrombin time. Total protein

Hepatitis C. Laboratory Tests and Hepatitis C

Relapsing remitting MS

CLL. Handheld record. Stockport NHS foundation trust

MS Treatments Aubagio TM

Lithium Therapy. Important information for patients COLLEGE CENTRE FOR QUALITY IMPROVEMENT

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

About MS. An introduction to. An introduction to multiple sclerosis for people who have recently been diagnosed. What is MS? Is it common?

Information Pathway. Myeloma tests and investigations. Paraprotein measurement

Routine Investigations for Liver Disease a guide

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

AUBAGIO Conversation Starter

Identifying and treating long-term kidney problems (chronic kidney disease)

Name of Child: Date: About Blood Cells

Multiple Myeloma Patient s Booklet

Use of oral steroids in Multiple Sclerosis

Welcome to. My plan for my life with

Radioactive Ra 223 therapy. Information for patients Weston Park Hospital

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

MEDICAL ASSISTANCE BULLETIN

Recruitment Start date: April 2010 End date: Recruitment will continue until enrolment is fully completed

Temozolomide (oral) with concurrent radiotherapy to the brain

Multiple Myeloma Understanding your diagnosis

Bio 20 Chapter 11 Workbook Blood and the Immune System Ms. Nyboer

University College Hospital. Hormone therapy for prostate cancer. Radiotherapy Department Patient information series

2016 Hospital National Patient Safety Goals

A handbook for people who have injected drugs

Appendix D- Monoclonal Gammopathy of Undetermined Significance (MGUS)

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO Gundersen Health System Center for Cancer and

Treating symptoms. An introduction to. Everyone diagnosed with MS can get treatment for their symptoms. The symptoms of MS. Who can get treatment?

What You Need to Know About Lung Cancer Immunotherapy

Disease modifying drug therapy

Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia.

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE

Multiple sclerosis disease-modifying drugs second line treatments

Acute myeloid leukaemia (AML) in children

If your doctor has ordered laboratory tests, it s natural

Rheumatoid arthritis inadults

And Now, Presenting...

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

National Hospital for Neurology and Neurosurgery

Recovery plan: radical cystectomy Information for patients

Critical Illness Claims Report 2006

Urgency and urge incontinence for patients with Multiple Sclerosis Patient Information Leaflet

Phasel clinical trials:

Patient Information Sheet

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Understanding How Existing and Emerging MS Therapies Work

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

Immune Cell Studies in Type 1 Diabetes (ISTID) INFORMATION SHEET FOR ADULTS WITH NEWLY- DIAGNOSED DIABETES. Sponsored by Cardiff University

How do I obtain copies of my medical records?

Peritoneal dialysis all you need to know about your blood results

Male New Patient Package

Treatment of low-grade non-hodgkin lymphoma

Voting for your top research questions Survey

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

DECISION QUALITY WORKSHEET TREATMENTS FOR SPINAL STENOSIS

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

GENERAL HEALTH SCREEN LAB REPORT. Date of Blood Draw: Time of Blood Draw: Fasting: Yes: X No:

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

EXECUTIVE BLOOD WORK PANEL

Hydroxyurea Treatment for Sickle Cell Disease

MS Treatments Gilenya

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

Care of the Catheterised Patient and Urinalysis

Hematology Morphology Critique

How prostate cancer is diagnosed

PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION

Pregnancy and hypothyroidism

Additional Blood Tests

Interpretation of Laboratory Values

Botox treatment for an overactive bladder in women. Information for patients Gynaecology

QUESTIONS TO ASK MY DOCTOR

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

UNDERSTANDING MULTIPLE MYELOMA AND YOUR TREATMENT. It is not known if REVLIMID is safe and effective in children under 18 years of age My Moment

Atrial Fibrillation and Anticoagulants

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway

Leflunomide Leflunomide

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

InDependent Diabetes Trust

Associates in Pediatric & Adult Urology, PA A division of Garden State Urology 282 Route 46 PO Box 1160 Denville, NJ 07834

BIOCHEMISTRY DEPARTMENT

Radiation Therapy for Prostate Cancer

Patient information leaflet for Termination of Pregnancy (TOP) / Abortion

Preventive Care Recommendations THE BASIC FACTS

1960 Ogden St. Suite 120, Denver, CO 80218,

Disease Modifying Therapies for MS

Choosing the Right Healthcare Providers. general information

MS and life choices. An introduction to. How can you make the best choices after your diagnosis with MS? What are life choices?

WHAT TO EXPECT FROM YOUR TREATMENT

BUPA Health Insurance (Thailand) Ltd. 104/9 Unit M02-03 The Avenue Chaengwattana Moo 1 Chaengwattana Tungsonghong Laksi Bangkok 10210

Transcription:

Your patient-held blood monitoring record book Disease-modifying treatment for multiple sclerosis (MS)

Your details Your current therapy: Name: Date of birth: Hospital/clinic: Hospital number: NHS number: Your healthcare staff Consultant neurologist: Contact number: MS specialist nurse: Contact number: GP: GP surgery address: What this booklet is for This booklet has been designed to record the details of your multiple sclerosis (MS) treatment and the results of your blood and urine tests. Keep this booklet in a safe place and make sure you take it with you when you go to see your consultant neurologist, GP, MS specialist nurse or pharmacist. About MS treatment and management The drugs used to treat MS generally act in some way on the white blood cells in your body, and may affect the way these cells behave and reduce your body s ability to fight infections. MS treatments can also affect how other organs such as the liver or kidneys work. When you start the treatment, your doctor or MS nurse will explain to you how the monitoring of your treatment will be managed. This may be by your hospital team, your MS specialist nurse or your GP, or it may be shared between them. GP surgery telephone: DMT delivery company: DMT company contact number: 2 Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book 3

About blood and urine monitoring Keeping this booklet up-to-date with your blood and/or urine test results will help your doctor or nurse to understand how well your body is coping with the treatment and will help to decide whether the treatment can continue or whether it needs to be modified. It is important that while you are receiving treatment: Record of your dose/treatment Current therapy: Date therapy was started or changed Reason Dosage and frequency Name of doctor or nurse you attend your clinic appointments regularly so that you can be carefully monitored you do not miss your blood and/or urine tests Your treatment may need to be stopped if you do not have the regular blood tests which have been specified by your neurologist or nurse. 4 CVT Disease-modifying short stay unittreatment for multiple sclerosis (MS) Your patient-held blood monitoring CVT short record stay book unit 5

Blood and urine tests monitoring record Test date Tests required Results Hb MCV WBC Neutrophils Lymphocytes Platelets Urea Creatinine Bilirubin ALT TSH T4 Urinalysis Blood Protein Urine microscopy Other 6 Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring CVT short record stay book unit 7

Blood and urine tests monitoring record Test date Tests required Results Hb MCV WBC Neutrophils Lymphocytes Platelets Urea Creatinine Bilirubin ALT TSH T4 Urinalysis Blood Protein Urine microscopy Other 8 CVT Disease-modifying short stay unittreatment for multiple sclerosis (MS) Your patient-held blood monitoring CVT short record stay book unit 9

Blood and urine tests monitoring record Test date Tests required Results Hb MCV WBC Neutrophils Lymphocytes Platelets Urea Creatinine Bilirubin ALT TSH T4 Urinalysis Blood Protein Urine microscopy Other 10 Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book 11

What the terms mean Different laboratories may have slightly different normal values from the ones in the table below. Ask your doctor or nurse to check that these normal values are right for your local area. Terms and normal values Hb Male 13.5-17.5 g/dl Female 12-16 g/dl MCV 80-100 fl WBC 4.0-11.0 x 10 9 /L Platelets 150-400 x 10 9 /L Lymphocytes 1.5-4.0 x 10 9 /L Neutrophils 2.0-7.5 x 10 9 /L Urea 2.5-8.0 mmol/l and creatinine 50-100 μmol/l Bilirubin < 20 μmol/l Explanation Haemoglobin is the oxygen-carrying protein inside red blood cells. Low levels may show that you are anaemic. The average volume of a red blood cell. White blood cells are important in fighting infections. The count can rise as a result of infection or from taking steroids. A low count may indicate that the treatment is harming the bone marrow. Platelets are essential for normal blood clotting. A low count may indicate that the treatment is harming the bone marrow or that the immune system is damaging the platelets. A type of white blood cell that has an important role in protecting your body from infections. It is expected to see some reduction in this cell count with many of the multiple sclerosis therapies. A type of white blood cell that usually increases quickly to fight infections. These are tests that help to show how your kidneys are working. This is a protein excreted in the liver. A raised level may indicate the liver is not working properly. Terms and normal values ALT/AST usually less than 40 u/l TSH 0.4-5.6 mu/l Free T4 7.5-21 pmol/l Urinalysis Urine Microscopy Explanation ALT/AST are tests to see how your liver is working. Rising blood ALT/AST levels may indicate liver inflammation. Thyroid function tests. These measure the function of the thyroid gland which can either become overactive or underactive. A urine dipstick is used to tell if there is any blood or protein in the urine. These may be present if there is a urinary tract infection but can sometimes be present if there is kidney damage. The urine is sent to a pathology laboratory for microscopy to see if red cell casts are present. These are an indicator of certain types of kidney damage which occur if the immune system is attacking the kidney. If you have any questions or concerns If you have any questions or concerns about your treatment or test results then please get in touch with your MS nurse or consultant using the contact numbers at the front of the booklet. 12 Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book 13

Further information The following organisations are able to offer further information and support: MS Society MS National Centre (MSNC) 372 Edgware Road London NW2 6ND Tel: 020 8438 0700 Fax: 020 8438 0701 www.mssociety.org.uk My notes Use this space to record anything you wish to make a note of, such as questions you would like to ask your healthcare professional next time you meet. Multiple Sclerosis Trust Spirella Building Bridge Road Letchworth Garden City Hertfordshire SG6 4ET Tel: 014 6247 6700 Free phone information service: 0800 032 3839 Fax: 014 6247 6710 Email: info@mstrust.org.uk www.mstrust.org.uk 14 Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book 15

Multiple sclerosis team Wessex Neurological Centre Southampton General Hospital Tremona Road Southampton SO16 6YD Multiple sclerosis office telephone: 023 8120 4194 If you need a translation of this document, an interpreter or a version in large print, Braille or on audiotape, please telephone 023 8120 4688 for help. www.uhs.nhs.uk 2015 University Hospital Southampton NHS Foundation Trust. All rights reserved. Not to be reproduced in whole or in part without the permission of the copyright holder. Version 1. Published March 2015. Due for review March 2018. 2015-850